Boryung Corporation (KRX: 003850)
South Korea
· Delayed Price · Currency is KRW 10,640
+360 (3.50%)
Dec 17, 2024, 3:30 PM KST
Boryung Company Description
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs.
The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022.
Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Boryung Corporation
| Country | South Korea |
| Founded | 1957 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,533 |
| CEO | Jay Kim |
Contact Details
Address: Boryeong Building Seoul, 03127 South Korea | |
| Phone | 82 2 708 8000 |
| Website | boryung.co.kr |
Stock Details
| Ticker Symbol | 003850 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003850005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Chang | Chief Executive Officer of Pharma Biz |
| Jay Kim | Chairman and Chief Executive Officer |
| Young-Ha Kim | Senior Managing Director, Director of Marketing Division and Director |
| Ho-Young Baek | Director of Operation Support Division and Director |